Rui Kishimoto

Effects of microvascular complications on structural changes in visceral and subcutaneous adiposity among type 2 diabetes patients

S. Nakanishi, Rui Kishimoto, Aya Hamaoka, 2016 .

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.

Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial

T. Kitamura, N. Kamei, S. Nakanishi, 2021, Diabetology International.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.